logo
Is Altria Group, Inc. (MO) the Best Performing Long Term Stock So Far in 2025?

Is Altria Group, Inc. (MO) the Best Performing Long Term Stock So Far in 2025?

Yahoo19-04-2025

We recently published a list of . In this article, we are going to take a look at where Altria Group, Inc. (NYSE:MO) stands against other best performing long term stocks so far in 2025.
Consumer morale fell more drastically than expected in April, owing to a surge in inflation expectations to unprecedented levels. According to the central bank's monthly Survey of Consumer Expectations, respondents expect inflation to reach 3.6% within a year, up 0.5 percentage points from February and the highest since October 2023. This increase in inflation fears was coupled by increased labor market unease, the assessed possibility that unemployment will rise in a year, surging to 44%. This represents a 4.6-point increase and the highest reading since the COVID-19 outbreak began in April 2020.
The survey results come amid growing concern over the possible economic impact of US President Donald Trump's planned tariffs. Many on Wall Street say they would fuel inflation and stifle economic development, while some analysts even fear that the United States may enter a recession within the next year. Meanwhile, Federal Reserve officials have expressed differing views, with some worrying that adjustments in consumer expectations might have immediate economic effects if they impact behavior.
Conversely, Federal Reserve Governor Christopher Waller remarked on April 14 that he anticipates the effects of President Donald Trump's tariffs on prices to be 'transitory,' using a word that landed the central bank in hot water during the previous bout of inflation. Waller believes the market could swing two different ways, stating that greater and longer-lasting tariffs would cause a larger inflation jump initially to 4% to 5%, which would later recede as the economy slowed and unemployment soared. In the other, smaller-tariff scenario, inflation would approach approximately 3% and then fall off. Waller added the following:
'Yes, I am saying that I expect that elevated inflation would be temporary, and 'temporary' is another word for transitory. Despite the fact that the last surge of inflation beginning in 2021 lasted longer than I and other policymakers initially expected, my best judgment is that higher inflation from tariffs will be temporary.'
However, Minneapolis Fed President Neel Kashkari has other concerns. The 10-year Treasury yield rose in the second week of this month after Trump stated his plans to impose a 10% tax on all U.S. trade partners and threatened to apply tougher, selective levies before backing down on April 9. At the same time, the dollar has fallen more than 3% compared to a basket of global currencies, perhaps signaling a shift away from safe-haven US assets. This is what Kashkari had to say:
'Investors around the world have viewed America as the best place to invest, and if that's true, we will have a trade deficit. So now one of the ways that expresses itself is in lower yields across asset classes in America. If the trade deficit is going to go down, it could be that investors are saying, OK, America no longer is the most attractive place in the world to invest, and then you would expect to see bond yields go up.'
For this list, we sifted through financial media reports and compiled a list of equities that are frequently referred to as long-term investments. We then chose the 10 stocks that were most popular among elite hedge funds and those that analysts were optimistic about. The names on this list appear in increasing order by the number of hedge funds that hold them as of Q4 2024.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
A close-up of an assembly line with a blend of tobacco products.
Altria Group, Inc. (NYSE:MO) is a prominent American company that produces and markets tobacco, cigarettes, and associated products on a global scale. The firm has also ventured into next-generation nicotine products, such as oral nicotine pouches and electronic vaping devices.
Altria Group, Inc. (NYSE:MO) released fourth-quarter profits for 2024, with earnings per share of $1.29, in line with market estimates, while revenues of $5.11 billion exceeded expectations of $5.04 billion. Looking ahead to 2025, Altria Group, Inc. (NYSE:MO) forecasts adjusted diluted EPS in the $5.22 to $5.37 range, indicating a 2% to 5% increase over its $5.12 EPS in 2024.
Following Altria's presentation at the CAGNY conference, Citi analyst Adam Spielman maintained a Neutral rating on the MO stock with a $52 price target. During the conference, Altria's leadership stressed the growth of overall US nicotine volumes, which have climbed at a compound annual growth rate of 2% over the last five years. This increase is linked to a shift in customer preferences toward vapor and current oral nicotine products. According to Altria Group, Inc. (NYSE:MO), heated tobacco products are predicted to account for 5% of the US nicotine market in the long term.
Andvari Associates stated the following regarding Altria Group, Inc. (NYSE:MO) in its Q1 2025 investor letter:
'Last year, Andvari made its first investments in tobacco companies with the purchase of Philip Morris International and Altria Group, Inc. (NYSE:MO). At the time of our purchase, Philip Morris and Altria had underperformed the S&P 500 over the prior 5- and 10-year periods. Both traded at low valuations and with high dividend yields. But thanks to following the industry o and on for 10+ years, and thanks to many discussions with long-time shareholders of the companies, Andvari felt the time was right to make the plunge. The timing could not have been much better for us as both companies have so far contributed positively to Andvari's recent overall performance.
Overall, MO ranks 8th on our list of best performing long term stocks so far in 2025. While we acknowledge the potential for MO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than MO but trades at less than 5 times its earnings, check out our report about the .
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i's Positive Phase 1 Results
Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i's Positive Phase 1 Results

Yahoo

time18 minutes ago

  • Yahoo

Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i's Positive Phase 1 Results

Metsera, Inc. (NASDAQ:MTSR) is one of the 13 Biotech Stocks with Huge Upside Potential. Metsera, Inc. (NASDAQ:MTSR) reported encouraging Phase 1 results for MET-233i, its once-monthly amylin analog, which showed a mean weight loss of up to 8.4% at Day 36 after subtracting the placebo. A laboratory technician researching a sample of cells in a biotechnology laboratory. The candidate supported monthly dosing with the longest half-life of any known amylin analog, 19 days. MET-233i had no safety indications and was well tolerated. The trial included 80 overweight or obese participants, with individual cases resulting in weight loss of up to 10.2%. MET-233i displayed high tolerability and dose-linear pharmacokinetics when tested in both single and multiple ascending dose formats. The majority of adverse gastrointestinal events occurred in the first week and were mild and dose-dependent. According to preliminary findings, it might make it practical to use its fully-biased GLP-1 RA candidate, MET-097i, in the first monthly GLP-1 + amylin combination therapy. Topline results from combination trials and an ongoing monotherapy study with MET-097i are anticipated in late 2025. Metsera, Inc. (NASDAQ:MTSR)'s HALO™ peptide stabilization platform supports the program. Metsera, Inc. (NASDAQ:MTSR) is a clinical-stage biopharmaceutical business focused on developing new treatments for obesity and metabolic diseases. It is one of the stocks with the biggest upside. While we acknowledge the potential of MTSR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Gold Advances on Middle East Tensions and Trump's Tariff Pledge
Gold Advances on Middle East Tensions and Trump's Tariff Pledge

Yahoo

time23 minutes ago

  • Yahoo

Gold Advances on Middle East Tensions and Trump's Tariff Pledge

(Bloomberg) -- Gold gained for a second day on increased tensions in the Middle East, with its haven status also supported by President Donald Trump's comments that he will inform trading partners on tariff rates within two weeks. Shuttered NY College Has Alumni Fighting Over Its Future Trump's Military Parade Has Washington Bracing for Tanks and Weaponry NYC Renters Brace for Price Hikes After Broker-Fee Ban NY Long Island Rail Service Resumes After Grand Central Fire NYC Mayoral Candidates All Agree on Building More Housing. But Where? Bullion rose as much as 0.6% to around $3,373 an ounce, extending a 1% gain from the earlier session when it was also boosted by a declining dollar. Buying interest increased after the US ordered some embassy staff to depart Baghdad and allowed military families to leave the Middle East, after Iran threatened to attack US bases if talks over its nuclear program fell through. Separately, Trump said he intended to send letters to trading partners in the next one to two weeks setting unilateral tariff rates, ahead of a July 9 deadline to reimpose higher duties on dozens of economies. The president also said a trade framework with China has been completed, with levies between the two largest economies to be maintained at their current levels. Uncertainties over global trade tensions and heightened geopolitical risks have rattled markets this year, boosting gold's allure as a store of value in turbulent times and powering a year-to-date advance of 28%. The precious metal, which reached an all-time high in April, has also been supported by increased central-bank buying. Spot gold was up 0.3% to $3,364.43 as of 7:59 a.m. Singapore time. The Bloomberg Dollar Spot Index was steady after falling 0.4% on Wednesday. Silver, platinum and palladium all gained. New Grads Join Worst Entry-Level Job Market in Years The Spying Scandal Rocking the World of HR Software American Mid: Hampton Inn's Good-Enough Formula for World Domination The SEC Pinned Its Hack on a Few Hapless Day Traders. The Full Story Is Far More Troubling Cavs Owner Dan Gilbert Wants to Donate His Billions—and Walk Again ©2025 Bloomberg L.P.

Dollar slides on easing trade tensions, Fed expectations
Dollar slides on easing trade tensions, Fed expectations

Yahoo

time23 minutes ago

  • Yahoo

Dollar slides on easing trade tensions, Fed expectations

By Rae Wee SINGAPORE (Reuters) -The dollar slid on Thursday on further signs that U.S. President Donald Trump may adopt a softer stance in tariff negotiations and heightened expectations of Federal Reserve rate cuts. Trump said on Wednesday he would be willing to extend a July 8 deadline for completing trade talks with countries before higher U.S. tariffs are imposed. U.S. Treasury Secretary Scott Bessent suggested earlier that the Trump administration may offer extensions from a July trade deal deadline for countries negotiating in good faith. The remarks renewed dollar weakness, lifting the euro to a seven-week high. It last bought $1.1525. The greenback lost 0.43% against the yen and 0.34% against the Swiss franc to last trade at 143.98 and 0.81725, respectively. Against a basket of currencies, the dollar fell to its weakest since April 22 at 98.327. "It's hard to tell whether there is a masterplan behind this, but common sense would suggest that President Trump is trying to create a level of urgency in terms of trade negotiations," said Rodrigo Catril, senior currency strategist at National Australia Bank. "I think the market, in terms of the size of the moves, is becoming a little bit more sanguine about what this all means... the market is also very wary that the picture could change quite dramatically in a week's time or two weeks' time." Elsewhere, sterling was up 0.38% to $1.3588. The Australian dollar ticked up 0.05% to $0.6506, while the New Zealand dollar rose 0.1% to $0.6033. On Wednesday, data showed U.S. consumer prices rose less than expected in May, leading traders to ramp up bets of a Fed cut as early as September and keeping pressure on the dollar. Thursday's producer price index data will be the next test for markets. The offshore yuan was last a touch stronger at 7.1953 per dollar, helped slightly by news that a fragile truce in the U.S.-China trade war was restored as both sides reached a deal following talks in London this week. "Full details have not been published, and it remains unclear if the talks brought the two largest economies closer to productive cooperation," said Mantas Vanagas, senior economist at Westpac. EURO STRENGTH The euro was clinging to strong gains on Thursday, having jumped against most other currencies in the previous session. Against the yen, the common currency last stood at 165.88 having risen to its firmest since October at 166.42 on Thursday. It was up 0.13% against the Aussie, extending a 0.9% gain from Thursday, and had also touched a one-month high of 84.88 pence overnight. While there was no immediate trigger behind the moves, analysts say the euro has over the past week drawn support from hawkish European Central Bank (ECB) rhetoric. Last week, the ECB cut interest rates as expected but hinted at a pause in its year-long easing cycle after inflation finally returned to its 2% target. "Expectations of fewer previously expected ECB rate cuts have lent some support to the euro," said Carol Kong, a currency strategist at Commonwealth Bank of Australia. That contrasts with the likely resumption of a Fed easing cycle later this year, and as Trump has repeatedly called for U.S. rates to be lowered. Trump said last week that a decision on the next Fed chief will be coming soon, adding that a good Fed chair would lower interest rates. The euro has risen nearly 11% for the year thus far, helped in part by a weaker dollar and as investors pour money into European markets in a move away from the U.S. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store